MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
158 hedge funds and large institutions have $500M invested in Momenta Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 61 increasing their positions, 40 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
158
Holders Change
+25
Holders Change %
+18.8%
% of All Funds
4.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
40
Increased
61
Reduced
40
Closed
15
Calls
$13M
Puts
$11.2M
Net Calls
+$1.84M
Net Calls Change
-$6.38M
Top Buyers
| 1 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
+$35.3M |
| 2 |
Primecap Management
Pasadena,
California
|
+$7.62M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$6.84M |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.01M |
| 5 |
Renaissance Technologies
New York
|
+$4.95M |
Top Sellers
| 1 |
VAM
Visium Asset Management
New York
|
-$64M |
| 2 |
DM
Deerfield Management
New York
|
-$20.1M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$6.93M |
| 4 |
PC
PointState Capital
New York
|
-$6.19M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.86M |
